<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03672708</url>
  </required_header>
  <id_info>
    <org_study_id>2018SDU-QILU-06</org_study_id>
    <nct_id>NCT03672708</nct_id>
  </id_info>
  <brief_title>Confocal Laser Endomicroscopy With Cresyl Violet for in Vivo Diagnosis of Gastric Intestinal Metaplasia</brief_title>
  <official_title>Cresyl Violet as a New Contrast Agent in Confocal Laser Endomicroscopy for in Vivo Diagnosis of Gastric Intestinal Metaplasia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shandong University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shandong University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Confocal laser endomicroscopy (CLE) is a novel endoscopic system which can provide
      approximately 1000-fold magnification of the gastrointestinal mucosa. Previous studies have
      demonstrated its diagnostic value for Gastric intestinal metaplasia (GIM) with the use of a
      contrast agent.Recently, Cresyl violet (CV) has been used in CLE to visualize tissue
      architecture in human ileum, colon or myenteric plexus.No investigation has reported the
      characterization of GIM imaged with CLE when using CV as staining dye
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 16, 2018</start_date>
  <completion_date type="Actual">January 2, 2019</completion_date>
  <primary_completion_date type="Actual">October 26, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>feasibility of CV for identifying GIM</measure>
    <time_frame>1 month</time_frame>
    <description>ratio of pCLE failure to visualize the cellular and subcellular structures</description>
  </primary_outcome>
  <primary_outcome>
    <measure>feasibility of CV for identifying GIM</measure>
    <time_frame>1 month</time_frame>
    <description>ratio of pCLE failure to recognize lesions and their immediate characterization</description>
  </primary_outcome>
  <primary_outcome>
    <measure>newly pCLE criteria with CV application for GIM</measure>
    <time_frame>1 month</time_frame>
    <description>ratio of diagnostic agreement between pCLE using CV and histopathological results</description>
  </primary_outcome>
  <primary_outcome>
    <measure>newly pCLE criteria with CV application for GIM</measure>
    <time_frame>1 month</time_frame>
    <description>number of diagnostic agreement between pCLE with CV application and histopathological results</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">48</enrollment>
  <condition>Gastric Intestinal Metaplasia</condition>
  <arm_group>
    <arm_group_label>Cresyl violet</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Cresyl violet</intervention_name>
    <description>cresyl violet is applicated at the concentration of 0.15% via a spraying catheter to visualize cellular and tissue architecture in the pCLE</description>
    <arm_group_label>Cresyl violet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients who had long-lasting upper gastrointestinal symptoms and aged 40 years or
             above

          -  patients with H. pylori infection, or known GIM or atrophic gastritis

        Exclusion Criteria:

          -  patients with a history of GI surgery

          -  advanced gastric carcinoma or any other malignancy in the GI tract

          -  acute upper GI bleeding

          -  patients with contraindications to CLE examination, such as coagulopathy, pregnancy,
             breast feeding, impaired renal or liver function

          -  patients refused to provide informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yanqing Li, PhD,MD</last_name>
    <role>Study Director</role>
    <affiliation>Department of Gastroenterology,Qilu Hospital,shandong University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Zhen Li, PhD,MD</last_name>
    <role>Study Director</role>
    <affiliation>Department of Gastroenterology,Qilu Hospital,shandong University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Gastroenterology, Qilu Hospital, Shandong University</name>
      <address>
        <city>Jinan</city>
        <state>Shandong</state>
        <zip>250012</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>August 3, 2018</study_first_submitted>
  <study_first_submitted_qc>September 13, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 14, 2018</study_first_posted>
  <last_update_submitted>May 10, 2019</last_update_submitted>
  <last_update_submitted_qc>May 10, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 14, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shandong University</investigator_affiliation>
    <investigator_full_name>Yanqing Li</investigator_full_name>
    <investigator_title>vice president of Qilu Hospital</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metaplasia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

